N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms-Reference-Cited by-同舟云学术

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: a double blind randomised placebo controlled trial targeting negative symptoms

Published:2016-09-15 Issue:1 Volume:16 Page:
ISSN:1471-244X
Container-title:BMC Psychiatry
language:en
Short-container-title:BMC Psychiatry

Author:

Rossell Susan L.,Francis Paul S.,Galletly Cherrie,Harris Anthony,Siskind Dan,Berk Michael,Bozaoglu Kiymet,Dark Frances,Dean Olivia,Liu Dennis,Meyer Denny,Neill Erica,Phillipou Andrea,Sarris Jerome,Castle David J.

Funder

National Health and Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Link

http://link.springer.com/content/pdf/10.1186/s12888-016-1030-3.pdf

Reference35 articles.

1. Morgan VA, Waterreus A, Jablensky A, Mackinnon A, McGrath JJ, Carr V, et al. People living with psychotic illness in 2010: The second Australian national survey of psychosis. Aust N Z J Psychiatry. 2012;46:735–52. doi: 10.1177/0004867412449877 .

2. McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, et al. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry. 2006;163:600–10.

3. Castle DJ, Keks N. What Can We Do If Clozapine Fails? Pharmacologic Choices and Differential Outcomes. Treatment–Refractory Schizophrenia. Heidelberg: Springer-Verlag; 2014. p. 93–106.

4. Deepmala A, Slattery J, Kumar N, Delhey L, Berk M, Dean O, Frye R. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neurosci Biobehav Rev. 2015;55:294–321. doi: 10.1016/j.neubiorev.2015.04.015 .

5. Berk M, Copolov D, Dean O, Lu K, Jeavons S, Schapkaitz I, et al. N-acetyl cysteine as a glutathione precursor for schizophrenia—a double-blind, randomized, placebo-controlled trial. Bio Psychiatry. 2008;64:361–8.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic Effects of n-Acethylcysteine on Inflammation-induced Depression-like Behaviors in Mice;Neuroscience;2024-06

2. Pterin metabolism, inflammation and oxidative stress biochemical markers in schizophrenia: Factor analysis and assessment of clinical symptoms associations;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2023-12

3. Verbal and visual learning ability in patients with treatment-resistant schizophrenia: A 1-year follow-up study;Schizophrenia Research: Cognition;2023-09

4. Effects of Medicinal Plants and Phytochemicals on Schizophrenia;Phytochemical Drug Discovery for Central Nervous System Disorders;2023-06-30

5. Biochemical disturbances in schizophrenia — a «window of opportunity»;V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY;2022-12-17